Valentina Tarasova, MD

Cancer Focus:
Adrenal Carcinoma, Adrenal Nodule/Mass, Neuroendocrine Tumor, Pituitary Macroadenoma, Pituitary Microadenoma, Pituitary Neoplasm, Thyroid Cancer, Thyroid Nodule/Mass

Dr. Tarasova is an Endocrinologist specializing in Endocrine Oncology at Moffitt Cancer Center. She completed an Internal Medicine Residency at Yale New Haven Hospital, Saint Raphael Campus, Yale School of Medicine in New Haven, CT and an Endocrinology, Diabetes and Metabolism Fellowship at the Creighton University in Omaha, NE. Most recently, Dr. Tarasova has completed an Interdisciplinary Medical Thyroid Cancer Fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. She also completed the Global Clinical Scholars Research Training (GCSRT) Program at Harvard Medical School in Boston, MA. Dr. Tarasova’s clinical interests include thyroid neoplasm, particularly diagnosis, monitoring and treatment of thyroid carcinoma (from low risk to advanced progressive forms of thyroid cancer). Her research interests include the role of molecular markers in diagnosing and determining the prognosis of thyroid neoplasm, risk stratification of patients with thyroid cancer and developing tools to estimate the prognosis and determine the management of patients with thyroid cancer.   

Education & Training

Board Certification:

• -

Fellowship:

• Creighton University - Endocrinology, Diabetes, Metabolism
• Memorial Sloan Kettering Cancer Center - Thyroid Cancer

Residency:

• Yale New Haven Hospital, Yale School of Medicine - Internal Medicine

Medical School:

• Kubansky State Medical University - MD

• Tasoulas J, Srivastava S, Xu X, Tarasova V, Maniakas A, Karreth FA, Amelio AL. Genetically engineered mouse models of head and neck cancers. Oncogene. 2023 Aug.42(35):2593-2609. Pubmedid: 37474617. Pmcid: PMC10457205.
• Hernandez-Prera J, Valderrabano P, Creed J, de la Iglesia JV, Slebos R, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder S, Lam C, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2021 Jan.31(1):36-49. Pubmedid: 32689909. Pmcid: PMC7864115.
• Bayona A, Benavent P, Muriel A, Abuchaibe C, Sharpe SC, Tarasova V, McIver B, Valderrabano P. Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules. Eur J Endocrinol. 2021 Aug.185(4):497-506. Pubmedid: 34313606.
• Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid. 2018 Feb.28(2):210-219. Pubmedid: 29160163. Pmcid: PMC7869885.
• Tarasova VD, Tuttle RM. Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma. Clin Oncol (R Coll Radiol). 2017 May.29(5):290-297. Pubmedid: 28087101.
• Tarasova VD, Tuttle RM. A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer. Rambam Maimonides Med J. 2016 Jan.7(1). Pubmedid: 26886955. Pmcid: PMC4737510.
• Shah KK, Tarasova V, Davidian M, Anderson RJ. Painful acute radiation thyroiditis induced by 131I treatment of Graves' disease. BMJ Case Rep. 2015 Jan.2015. Pubmedid: 25576511. Pmcid: PMC4289741.
• Tarasova VD, Caballero JA, Turner P, Inzucchi SE. Speaking to Patients About Diabetes Risk: Is Terminology Important?. Clin Diabetes. 2014 Apr.32(2):90-95. Pubmedid: 26130869. Pmcid: PMC4485246.
• Tarasova VD, Zena M, Rendell M. Artifactual hypoglycemia: an old term for a new classification. Diabetes Care. 2014.37(5):e85-e86. Pubmedid: 24757247.
• Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, Chong WH, Collins MT, Armas LA. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy. J Clin Endocrinol Metab. 2013 Nov.98(11):4267-4272. Pubmedid: 24014621. Pmcid: PMC5399525.